Funmilola Eunice Adewinle
Research Subjects
Research Interests
Funmilola Eunice Adewinle has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Austėja Dapkutė
Centre of Neurology, Vilnius University, Vilnius, Lithuania
1 shared publication Chiara Rosignoli
University of L'Aquila
1 shared publication- Davide Mascarella
IRCCS Istituto delle Scienze Neurologiche di Bologna, Ausl Bologna, Bologna, Italy
1 shared publication - Edoardo Caronna
Headache and Neurological Pain Research Group, Vall d’Hebron Research Institute, Department of Neuroscience, Universitat Autònoma de Barcelona, Barcelona, Spain
1 shared publication Elena Mazzotta
University of Pavia
1 shared publicationElijah Olufemi Oyetola
1 shared publication
Latest Publications
- 12 December 2025
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology
- Vol. 38 (3) , 465-470
Neuropathic orofacial pain is associated with low serum vitamin D: A case control study
- 12 December 2025
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology
- Vol. 38 (3) , 465-470
Neuropathic orofacial pain is associated with low serum vitamin D: A case control study
- Open Access
- 28 October 2025
- Published by SAGE Publications in Cephalalgia
- Vol. 45 (10)
Migraine in monogenic disorders: Shedding light on new therapeutic targets
Background: Migraine is a common neurological disorder with a strong genetic component, yet the precise mechanisms underlying its genetic susceptibility remain largely unknown. Genome-wide association studies (GWAS) have identified multiple risk loci, but monogenic forms of migraine, particularly Familial Hemiplegic Migraine (FHM), have provided deeper insights into the pathophysiology of migraine. Studying monogenic disorders that present migraine as a symptom could help identify novel therapeutic targets by uncovering shared molecular pathways. Methods: A narrative literature review was conducted using a stepwise approach in the PubMed database. Reviewers were divided into three groups, each focusing on different aspects of migraine genetics. The first group analyzed monogenic migraine syndromes, including FHM and related ion-channelopathies. The second group examined clinical manifestations and phenotypic spectrum of FHM-related genes. The third group expanded the search to other monogenic disorders associated with migraine, such as Cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS), and Familial Advanced Sleep Phase Syndrome (FASPS). Additional searches were conducted using the Compendium of Causative Genes for Monogenic Disorders. Results: The review identified multiple monogenic disorders associated with migraine, revealing distinct but interconnected mechanisms. Ion-channel dysfunction ( CACNA1A , SCN1A , ATP1A2 ), vascular impairment ( NOTCH3 , TREX1 ), mitochondrial dysfunction ( MT-TL1 ), and circadian dysregulation ( CSNK1D ) emerged as critical contributors to migraine pathophysiology. These findings highlight the roles of neuronal excitability, cortical spreading depression, trigeminal sensitization, and neurovascular dysfunction in migraine. Conclusions: Monogenic migraine disorders offer valuable insights into migraine pathogenesis, emphasizing the importance of ion homeostasis, vascular function, and circadian regulation. Although genetic studies have not yet directly translated into new therapeutic targets, the study and knowledge of these rare conditions is pivotal for neurologists and migraine specialists, as it might improve diagnosis and care, and provide new insights into migraine pathophysiology that may ultimately inform future treatments.
- 28 October 2025
- Published by SAGE Publications in Cephalalgia
- Vol. 45 (10)
Open AccessMigraine in monogenic disorders: Shedding light on new therapeutic targets
Background: Migraine is a common neurological disorder with a strong genetic component, yet the precise mechanisms underlying its genetic susceptibility remain largely unknown. Genome-wide association studies (GWAS) have identified multiple risk loci, but monogenic forms of migraine, particularly Familial Hemiplegic Migraine (FHM), have provided deeper insights into the pathophysiology of migraine. Studying monogenic disorders that present migraine as a symptom could help identify novel therapeutic targets by uncovering shared molecular pathways. Methods: A narrative literature review was conducted using a stepwise approach in the PubMed database. Reviewers were divided into three groups, each focusing on different aspects of migraine genetics. The first group analyzed monogenic migraine syndromes, including FHM and related ion-channelopathies. The second group examined clinical manifestations and phenotypic spectrum of FHM-related genes. The third group expanded the search to other monogenic disorders associated with migraine, such as Cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS), and Familial Advanced Sleep Phase Syndrome (FASPS). Additional searches were conducted using the Compendium of Causative Genes for Monogenic Disorders. Results: The review identified multiple monogenic disorders associated with migraine, revealing distinct but interconnected mechanisms. Ion-channel dysfunction ( CACNA1A , SCN1A , ATP1A2 ), vascular impairment ( NOTCH3 , TREX1 ), mitochondrial dysfunction ( MT-TL1 ), and circadian dysregulation ( CSNK1D ) emerged as critical contributors to migraine pathophysiology. These findings highlight the roles of neuronal excitability, cortical spreading depression, trigeminal sensitization, and neurovascular dysfunction in migraine. Conclusions: Monogenic migraine disorders offer valuable insights into migraine pathogenesis, emphasizing the importance of ion homeostasis, vascular function, and circadian regulation. Although genetic studies have not yet directly translated into new therapeutic targets, the study and knowledge of these rare conditions is pivotal for neurologists and migraine specialists, as it might improve diagnosis and care, and provide new insights into migraine pathophysiology that may ultimately inform future treatments.